Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
XAIRthis companyBeyond Air, Inc.	$2.23	-3.44×	18.7×	14.92×	-4.28×	513.4%	3.3%	-378.2%	-433.0%	-542.8%	-98.1%	-16.7%	3.82×	-0.54×	0×	3.8×	0.0%	3	-16.43	1	D+
AEONAEON Biopharma, Inc.	$0.18	-0.28×	-0.2×	0×	-2.69×	-1320.4%	0.0%	0.0%	0.0%	71.3%	1180.0%	-158.6%	-0.65×	-2.02×	0×	0.49×	0.0%	2	-129.27	2	C
BOLTBolt Biotherapeutics, Inc.	$6.35	-0.31×	0.39×	1.33×	-0.67×	-1476.7%	80.6%	-450.1%	-433.7%	-125.9%	-67.7%	-390.3%	0.87×	-0.35×	0×	3.59×	0.0%	2	-18.11	2	C
CLRBCellectar Biosciences, Inc.	$1.31	-0.35×	0.78×	0×	0.24×	259.5%	0.0%	0.0%	0.0%	-219.7%	-222.5%	-300.5%	0.04×	0.59×	0×	2.96×	0.0%	2	-10.78	3	B
CODXCo-Diagnostics, Inc.	$0.27	-0.14×	0.33×	10.83×	0.08×	1999.8%	64.3%	-5025.5%	-7533.6%	-227.3%	-138.3%	-442.4%	0.06×	0.22×	0×	3.87×	0.0%	2	-17.12	3	B-
SINTSintx Technologies, Inc.	$1.49	-0.63×	3.66×	10.52×	-1.02×	-554.2%	-19.7%	-1053.1%	-1678.1%	-583.2%	-173.5%	-81.8%	1.11×	0.09×	-206.17×	1.51×	0.0%	3	-41.74	1	C-
Peer median	—	-0.31×	0.39×	1.33×	-0.67×	-554.2%	0.0%	-450.1%	-433.7%	-219.7%	-138.3%	-300.5%	0.06×	0.09×	0×	2.96×	0.0%	2	-18.11	2	—